SEHK:3309

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

C-MER Eye Care Holdings

Executive Summary

C-MER Eye Care Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and the People’s Republic of China. More Details


Snowflake Analysis

Flawless balance sheet with weak fundamentals.

Share Price & News

How has C-MER Eye Care Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 3309 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 3309's weekly volatility (6%) has been stable over the past year.


Market Performance


7 Day Return

1.8%

3309

12.1%

HK Healthcare

3.5%

HK Market


1 Year Return

10.3%

3309

-7.6%

HK Healthcare

15.1%

HK Market

Return vs Industry: 3309 exceeded the Hong Kong Healthcare industry which returned -7.6% over the past year.

Return vs Market: 3309 underperformed the Hong Kong Market which returned 15.1% over the past year.


Shareholder returns

3309IndustryMarket
7 Day1.8%12.1%3.5%
30 Day-1.4%12.4%12.7%
90 Day-1.1%25.5%18.1%
1 Year10.7%10.3%-5.1%-7.6%19.7%15.1%
3 Year-53.8%-54.2%-41.6%-45.3%-5.1%-15.1%
5 Yearn/a-24.0%-31.3%65.1%37.0%

Long-Term Price Volatility Vs. Market

How volatile is C-MER Eye Care Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is C-MER Eye Care Holdings undervalued compared to its fair value and its price relative to the market?

5.21x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: 3309 (HK$5.58) is trading above our estimate of fair value (HK$0.31)

Significantly Below Fair Value: 3309 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 3309 is unprofitable, so we can't compare its PE Ratio to the HK Healthcare industry average.

PE vs Market: 3309 is unprofitable, so we can't compare its PE Ratio to the Hong Kong market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 3309's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 3309 is overvalued based on its PB Ratio (5.2x) compared to the HK Healthcare industry average (1.5x).


Next Steps

Future Growth

How is C-MER Eye Care Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

26.9%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as C-MER Eye Care Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has C-MER Eye Care Holdings performed over the past 5 years?

-13.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 3309 is currently unprofitable.

Growing Profit Margin: 3309 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 3309 is unprofitable, and losses have increased over the past 5 years at a rate of 13.6% per year.

Accelerating Growth: Unable to compare 3309's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 3309 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-9.1%).


Return on Equity

High ROE: 3309 has a negative Return on Equity (-1.32%), as it is currently unprofitable.


Next Steps

Financial Health

How is C-MER Eye Care Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: 3309's short term assets (HK$630.5M) exceed its short term liabilities (HK$118.6M).

Long Term Liabilities: 3309's short term assets (HK$630.5M) exceed its long term liabilities (HK$133.2M).


Debt to Equity History and Analysis

Debt Level: 3309 is debt free.

Reducing Debt: 3309 has no debt compared to 5 years ago when its debt to equity ratio was 75.4%.

Debt Coverage: 3309 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 3309 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is C-MER Eye Care Holdings's current dividend yield, its reliability and sustainability?

0.36%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 3309's dividend (0.36%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (2.09%).

High Dividend: 3309's dividend (0.36%) is low compared to the top 25% of dividend payers in the Hong Kong market (6.55%).


Stability and Growth of Payments

Stable Dividend: 3309 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are stable.

Growing Dividend: 3309 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: 3309 is not paying a notable dividend for the Hong Kong market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 3309's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.3yrs

Average board tenure


CEO

Dennis Lam (60 yo)

no data

Tenure

HK$1,218,000

Compensation

Dr. Shun Chiu Lam, also known as Dennis, JP, serves as Chairman and Chief Executive Officer of C-MER Eye Care Holdings Ltd. Dr. Lam is also a director of certain subsidiaries of the Company. Dr. Lam is fou...


CEO Compensation Analysis

Compensation vs Market: Dennis's total compensation ($USD157.11K) is below average for companies of similar size in the Hong Kong market ($USD424.68K).

Compensation vs Earnings: Dennis's compensation has been consistent with company performance over the past year.


Board Members

NamePositionTenureCompensationOwnership
Shun Chiu Lam
Chairman & CEOno dataHK$1.22mno data
Xiaoting Li
Executive Directorno dataHK$2.00mno data
Yau Wing Lee
Executive Director3.58yrsHK$1.03m1.09%
HK$ 69.5m
Chunshan Li
Executive Director3.58yrsHK$536.00k0.090%
HK$ 5.8m
Chiu Cheung Ma
Independent Non-Executive Director3.25yrsHK$240.00kno data
Pak-kuen Auyeung
Independent Non-Executive Director0.17yrno data0.026%
HK$ 1.7m
Shu Kwan Ip
Independent Non-Executive Director0.17yrno datano data
Kwok Tung Li
Independent Non-Executive Director3.25yrsHK$240.00kno data
Chi Leong Chan
Independent Non-Executive Director3.25yrsHK$240.00k0.24%
HK$ 15.4m
Annie Liang Bentley
Independent Non-Executive Director3.25yrsHK$240.00kno data

3.3yrs

Average Tenure

68yo

Average Age

Experienced Board: 3309's board of directors are considered experienced (3.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: 3309 insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.1%.


Top Shareholders

Company Information

C-MER Eye Care Holdings Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: C-MER Eye Care Holdings Limited
  • Ticker: 3309
  • Exchange: SEHK
  • Founded: 2012
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: HK$6.402b
  • Shares outstanding: 1.15b
  • Website: https://www.cmereye.com

Number of Employees


Location

  • C-MER Eye Care Holdings Limited
  • Central Building
  • Suite 1535
  • Central
  • Hong Kong

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
3309SEHK (The Stock Exchange of Hong Kong Ltd.)YesOrdinary SharesHKHKDJan 2018
3309SZSC (The Stock Exchange of Hong Kong - Shenzhen - Hong Kong Stock Connect)YesOrdinary SharesHKHKDJan 2018
3309SHSC (Stock Exchange of Hong Kong Limited - Shanghai - Hong Kong Stock Connect)YesOrdinary SharesHKHKDJan 2018

Biography

C-MER Eye Care Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and the People’s Republic of China. The company operates eye ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/01/23 10:24
End of Day Share Price2021/01/22 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.